Cargando…
SG-APSIC1054: Sputnik-V postvaccination immunologic responses in nasal mucosa: A prospective cohort study in Kazakhstan
Objectives: Sputnik-V (Gam-COVID-Vac) is a recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in >70 countries. Mucosal immunity is thought to be important for protection against COVID-19. We did a prospective cohort study to assess Sputnik-V–elicited mucosal SARS-CoV-2 antibod...
Autores principales: | Kadyrova, Irina, Kolesnichenko, Svetlana, Korshukov, Ilya, Kolesnikova, Yevgeniya, Negmetzhanov, Baurzhan, Baiken, Yeldar, Sultanbekova, Aidana, Yegorov, Sergey, Babenko, Dmitriy, Matkarimov, Bakhyt, Hortelano, Gonzalo, Miller, Matthew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565797/ http://dx.doi.org/10.1017/ash.2023.13 |
Ejemplares similares
-
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
por: Yegorov, Sergey, et al.
Publicado: (2022) -
SG-APSIC1053: Detection of SARS-COV-2 in nasopharyngeal swags with MALDI-TOF MS and machine learning
por: Kadyrova, Irina, et al.
Publicado: (2023) -
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
por: Kadyrova, Irina, et al.
Publicado: (2022) -
Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook
por: Ashimova, Assem, et al.
Publicado: (2019) -
Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study
por: Ashimova, Assem, et al.
Publicado: (2022)